Search results
- 1.0343928 - ÚEB 2011 RIV CH eng J - Journal Article
Kryštof, Vladimír - McNae, I. W. - Walkinshaw, M. D. - Fischer, P.M. - Müller, P. - Vojtešek, B. - Orság, Martin - Havlíček, Libor - Strnad, Miroslav
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor.
Cellular and Molecular Life Sciences. Roč. 62, č. 15 (2005), s. 1763-1771. ISSN 1420-682X. E-ISSN 1420-9071
R&D Projects: GA ČR GP204/03/D231
Institutional research plan: CEZ:AV0Z50380511
Keywords : olomoucine II * roscovitine * cyclin-dependent kinase inhibitor
Subject RIV: CE - Biochemistry
Impact factor: 4.582, year: 2005
Permanent Link: http://hdl.handle.net/11104/0186288 - 2.0098696 - ÚEB 2008 RIV US eng J - Journal Article
Kryštof, Vladimír - Cankař, Petr - Fryšová, I. - Slouka, J. - Kontopidis, G. - Džubák, P. - Hajdúch, M. - Srovnal, J. - de Azevedo Jr., W.F. - Orság, Martin - Paprskářová, Martina - Rolčík, Jakub - Látr, Aleš - Fischer, P.M. - Strnad, Miroslav
4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.
[4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.]
Journal of Medicinal Chemistry. Roč. 49, č. 22 (2006), s. 6500-6509. ISSN 0022-2623. E-ISSN 1520-4804
R&D Projects: GA ČR GA301/05/0418
Institutional research plan: CEZ:AV0Z50380511
Source of funding: V - Other public resources
Keywords : DEPENDENT KINASE INHIBITORS * POLYMERASE-II TRANSCRIPTION * TUMOR-NECROSIS-FACTOR
Subject RIV: CE - Biochemistry
Impact factor: 5.115, year: 2006
Permanent Link: http://hdl.handle.net/11104/0157542 - 3.0083397 - ÚEB 2008 RIV GB eng J - Journal Article
Havlíček, Libor - Fuksová, Květoslava - Kryštof, Vladimír - Orság, Martin - Vojtěšek, B. - Strnad, Miroslav
8-Azapurines as new inhibitors of cyclin-dependent kinases.
[8-Azapurines as new inhibitors of cyclin-dependent kinases.]
Bioorganic & Medicinal Chemistry. Roč. 13, č. 8 (2005), s. 5399-5407. ISSN 0968-0896. E-ISSN 1464-3391
R&D Projects: GA AV ČR KJB6137301; GA ČR GA301/05/0418
Institutional research plan: CEZ:AV0Z50380511
Source of funding: V - Other public resources ; V - Other public resources
Keywords : CDK2 * Inhibitor * Anticancer drug
Subject RIV: FD - Oncology ; Hematology
Impact factor: 2.286, year: 2005
Permanent Link: http://hdl.handle.net/11104/0146656